♢ At the end of a title indicates that the FDA has not cleared prescription drugs, approved medical devices and/or biologics for the use described in this presentation. The prescription drugs, approved medical devices and/or biologics are being discussed for an off-label use.

Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Name
      Event Title
        Event Type
          Category-Classification
            Event Day

              139 Does PSI in total ankle arthroplasty affect joint line levels and functional outcomes?

              Author:Cesare Faldini, MD  Alberto Arceri, MD  Simone Ottavio Zielli, MD  Federico Sgubbi, MD  Laura Langone, MD  Gianmarco Di Paola, MD  Antonio Mazzotti, MD  

              Event Title:(138-145) VIPER: Foot and Ankle I Papers  

              Event Type:Paper Presentations  

              Category-Classification:Foot and Ankle  

              Event Day:Monday, March 10  

              157 Comparing Outcomes of Medicare and Other Insurance Groups in TKA: Insights for CMS' Upcoming Mandatory PROMs Reporting Policy

              Author:Ignacio Pasqualini, MD  Shujaa Khan  Alison Klika  Chao Zhang, MS  Peter Surace, MD  Matthew Deren, MD, FAAOS  Robert Molloy, MD  Viktor Erik Krebs, MD,FAAOS  Nicolas Piuzzi, MD  

              Event Title:(146-157) VIPER: Adult Reconstruction Knee II Papers  

              Event Type:Paper Presentations  

              Category-Classification:Adult Reconstruction Knee  

              Event Day:Tuesday, March 11  

              158 What if all Femoral Neck Fractures in the US were cemented? A population-level cost-effectiveness analysis from the American Joint Replacement Registry.

              Author:Bryan Springer, MD,FAAOS  Antonia Chen, MD,MBA,FAAOS  Ross Crawford, MD  Robin Blythe, MPH  Ayushmita De  Nicholas Graves, PhD  

              Event Title:(158-169) VIPER: Trauma III Papers  

              Event Type:Paper Presentations  

              Category-Classification:Trauma  

              Event Day:Tuesday, March 11  

              160 Despite Higher Upfront Costs, Cemented Hemiarthroplasty Results in Substantial Cost Savings Over the Long Term Compared to Uncemented Hemiarthroplasty for the Treatment of Femoral Neck Fractures: A Markov Analysis

              Author:Jacob Oeding, MS  Nathan Varady, MD,MBA  Elizabeth Gausden, MD  William Ricci, MD,FAAOS  Antonia Chen, MD,MBA,FAAOS  

              Event Title:(158-169) VIPER: Trauma III Papers  

              Event Type:Paper Presentations  

              Category-Classification:Trauma  

              Event Day:Tuesday, March 11  

              161 Timing of Direct Oral Anticoagulant Usage Does Not Negatively Impact Outcomes Following Hip Arthroplasty for Femoral Neck Fractures

              Author:Xiao Tony Chen, MD  Bryan Springer, MD,FAAOS  Shalmali Borkar, MBBS, MPH  Aaron Spaulding  Linjun Yang, PhD  Cody Wyles, MD  Steven Porter, MD  Joshua Bingham, MD, FAAOS  Benjamin Wilke, MD,FAAOS  

              Event Title:(158-169) VIPER: Trauma III Papers  

              Event Type:Paper Presentations  

              Category-Classification:Trauma  

              Event Day:Tuesday, March 11